data_1iyt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iyt _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.95 -37.62 0.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.582 1.537 . . . . 0.0 111.719 169.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.75 -50.94 62.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.27 -55.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.095 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -52.66 -53.29 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.223 1.409 . . . . 0.0 111.586 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -62.96 -47.2 84.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.66 78.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.988 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -59.18 -53.44 58.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.78 0.832 . . . . 0.0 110.057 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.16 -48.24 71.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.342 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.47 -49.62 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.355 0.598 . . . . 0.0 111.072 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -53.84 41.21 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 123.329 0.651 . . . . 0.0 112.024 177.3 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -36.83 75.79 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.613 1.551 . . . . 0.0 109.522 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.04 -49.51 15.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -167.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -57.45 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.369 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -57.03 -57.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.327 0.651 . . . . 0.0 109.586 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.3 -48.34 80.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.58 -45.07 73.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.463 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.3 -49.14 76.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.008 0.822 . . . . 0.0 111.652 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -10.05 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.953 0.901 . . . . 0.0 112.65 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -97.11 -60.4 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.433 1.493 . . . . 0.0 109.475 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -49.43 63.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 125.517 1.532 . . . . 0.0 110.85 -170.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 122.861 0.464 . . . . 0.0 110.666 -179.316 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -35.68 81.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.71 -50.9 65.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.33 -59.22 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.535 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.84 -50.03 61.68 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 111.486 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -61.93 -51.11 69.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.83 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -60.89 -48.53 81.37 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.803 0.841 . . . . 0.0 112.022 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.82 -53.58 54.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 108.685 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.52 -51.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.686 0.794 . . . . 0.0 110.56 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.78 -50.74 56.9 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.4 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 123.773 0.829 . . . . 0.0 111.85 179.442 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -29.23 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.972 1.714 . . . . 0.0 109.449 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -10.45 59.4 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.297 0.373 . . . . 0.0 110.192 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.02 -58.86 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.002 1.321 . . . . 0.0 109.384 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -39.74 -55.1 1.99 Allowed 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 126.936 2.094 . . . . 0.0 111.61 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.31 -47.44 85.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.785 0.721 . . . . 0.0 110.371 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.81 90.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.088 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.78 -42.98 99.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.789 0.435 . . . . 0.0 111.955 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.7 -45.28 87.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.461 1.104 . . . . 0.0 108.974 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.04 -57.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.546 0.688 . . . . 0.0 110.358 171.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.39 -47.37 69.26 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.519 1.057 . . . . 0.0 110.638 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.451 -0.377 0 C-N-CA 123.628 0.771 . . . . 0.0 112.763 -176.811 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -59.83 -30.29 68.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.162 0.985 . . . . 0.0 109.124 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -69.5 -48.21 61.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.98 -51.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.74 -53.14 34.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 0.0 110.765 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.27 -47.96 83.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.227 -0.296 . . . . 0.0 110.355 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.83 -48.9 50.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.272 0.629 . . . . 0.0 109.613 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -51.46 68.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.371 0.668 . . . . 0.0 112.395 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -54.25 -50.16 67.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.763 0.825 . . . . 0.0 109.473 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.73 -55.08 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.871 0.868 . . . . 0.0 110.623 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.91 51.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 124.233 1.013 . . . . 0.0 112.227 179.596 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.49 -40.91 1.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.912 0.885 . . . . 0.0 111.578 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.79 -32.84 65.87 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -172.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.69 -58.54 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -50.22 -54.71 19.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.961 1.305 . . . . 0.0 111.093 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -61.45 -50.37 73.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.073 0.397 . . . . 0.0 110.197 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.81 67.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.145 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.25 -51.12 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.116 0.566 . . . . 0.0 111.704 174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.01 -19.27 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.014 0.926 . . . . 0.0 111.29 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -57.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 109.726 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.02 -50.94 58.76 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.934 1.255 . . . . 0.0 110.358 -169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 123.547 0.739 . . . . 0.0 111.351 179.379 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -35.29 60.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.396 1.453 . . . . 0.0 109.531 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.268 1.6 pp -77.3 -46.28 23.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.57 -48.33 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.846 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.36 -51.0 71.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.803 1.241 . . . . 0.0 110.004 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.91 -48.06 83.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.75 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.188 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.4 -44.74 86.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.99 -37.16 78.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.03 -53.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.483 0.659 . . . . 0.0 110.678 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.35 94.44 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -172.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.317 -172.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.253 24.6 pt20 . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.78 -36.37 16.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.612 1.551 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -25.02 55.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -171.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -89.96 -52.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.46 1.104 . . . . 0.0 109.524 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -48.32 -52.0 23.54 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.65 1.98 . . . . 0.0 109.952 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -58.12 -50.36 73.76 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.235 0.925 . . . . 0.0 110.744 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -49.52 65.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -56.96 -46.96 81.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.186 0.594 . . . . 0.0 112.465 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -8.55 48.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.604 1.162 . . . . 0.0 112.053 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.78 -57.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.847 1.259 . . . . 0.0 108.556 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.7 -56.56 15.31 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.295 1.426 . . . . 0.0 110.911 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.452 -0.354 0 C-N-CA 123.631 0.772 . . . . 0.0 112.446 -177.201 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 12.9 pt20 . . . . . 0 N--CA 1.445 -0.725 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.09 66.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 120.003 1.274 . . . . 0.0 109.91 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -16.97 61.11 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.917 -0.489 . . . . 0.0 109.94 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.3 -62.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.304 1.041 . . . . 0.0 109.241 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.88 -47.07 78.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.298 1.439 . . . . 0.0 111.158 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.18 -48.33 73.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.008 0.822 . . . . 0.0 109.472 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.89 72.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.217 0.607 . . . . 0.0 110.922 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.02 -50.47 70.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.716 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -51.99 65.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -58.51 -56.08 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.492 0.717 . . . . 0.0 110.193 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.45 -55.04 30.54 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -35.65 65.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.985 1.266 . . . . 0.0 108.633 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.14 -16.34 61.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.3 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.68 -53.47 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.609 1.163 . . . . 0.0 109.911 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -52.65 -49.46 65.15 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.724 1.61 . . . . 0.0 110.316 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.57 -47.16 87.4 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.586 0.63 . . . . 0.0 109.852 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.84 83.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.574 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -58.73 -49.73 76.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.96 0.504 . . . . 0.0 111.672 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -29.31 69.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.531 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.82 -56.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.41 0.624 . . . . 0.0 110.253 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.62 -49.78 67.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.65 1.119 . . . . 0.0 110.767 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 123.918 0.887 . . . . 0.0 111.027 -176.388 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.2 -72.13 0.18 Allowed 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.406 0.683 . . . . 0.0 109.262 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -140.05 5.11 2.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.506 0.722 . . . . 0.0 112.815 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.98 -33.71 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.402 0.681 . . . . 0.0 110.56 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -75.56 -57.16 4.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.919 0.888 . . . . 0.0 110.941 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -77.87 58.42 1.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.748 0.819 . . . . 0.0 111.657 -170.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.38 -60.46 1.52 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 109.853 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -53.4 -51.21 63.28 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.9 -0.5 . . . . 0.0 110.732 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.36 -14.73 57.74 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.836 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.33 -54.74 4.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.024 1.412 . . . . 0.0 108.566 171.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.91 -30.2 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.138 1.375 . . . . 0.0 112.94 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.495 ' CG1' ' H ' ' A' ' 13' ' ' HIS . 3.9 p -44.31 -80.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.147 0.979 . . . . 0.0 110.879 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.495 ' H ' ' CG1' ' A' ' 12' ' ' VAL . 48.9 m80 -58.92 -39.69 82.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.867 0.867 . . . . 0.0 110.812 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -44.49 -37.74 3.68 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.414 0.446 . . . . 0.0 110.298 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -98.21 -52.7 3.59 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.95 -37.62 0.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.582 1.537 . . . . 0.0 111.719 169.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.75 -50.94 62.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.27 -55.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.095 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -52.66 -53.29 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.223 1.409 . . . . 0.0 111.586 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -62.96 -47.2 84.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.66 78.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.988 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -59.18 -53.44 58.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.78 0.832 . . . . 0.0 110.057 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.16 -48.24 71.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.342 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.47 -49.62 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.355 0.598 . . . . 0.0 111.072 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -53.84 41.21 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 m -81.26 30.11 0.34 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.329 0.651 . . . . 0.0 112.024 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -156.6 32.36 0.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.176 0.99 . . . . 0.0 110.394 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -58.4 -39.39 79.57 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.74 0.816 . . . . 0.0 109.834 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.44 -31.75 5.05 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.028 0.823 . . . . 0.0 112.353 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.54 -54.23 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.521 0.661 . . . . 0.0 110.489 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.257 2.0 mp -64.56 -10.46 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -31.51 -41.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 127.9 2.48 . . . . 0.0 112.657 167.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.56 -53.57 12.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.571 0.623 . . . . 0.0 112.067 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -41.0 83.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.402 1.081 . . . . 0.0 109.862 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -54.88 -51.15 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.01 -44.64 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.349 0.66 . . . . 0.0 109.598 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.38 -27.97 61.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.436 1.017 . . . . 0.0 111.63 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.5 -16.6 48.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.511 1.053 . . . . 0.0 112.52 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.65 -36.37 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.708 1.254 . . . . 0.0 110.228 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.12 -40.0 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.44 176.88 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.7 -1.619 . . . . 0.0 111.322 177.417 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.34 -63.58 0.38 Allowed 'General case' 0 C--N 1.338 0.093 0 C-N-CA 126.21 1.804 . . . . 0.0 111.718 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -105.59 157.09 17.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.8 t80 77.83 -50.41 0.51 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.998 1.719 . . . . 0.0 110.675 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -32.96 72.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.106 0.962 . . . . 0.0 110.947 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -56.79 -25.61 55.89 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.37 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.37 31.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.149 1.779 . . . . 0.0 113.347 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m -52.79 -50.05 64.37 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.84 1.2 . . . . 0.0 111.067 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.35 70.63 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 -62.01 1.7 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -48.05 -33.49 8.12 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 127.205 2.202 . . . . 0.0 112.467 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -46.18 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.329 1.052 . . . . 0.0 110.7 172.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -77.63 -41.56 38.0 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 122.905 0.482 . . . . 0.0 110.188 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -49.69 -46.38 49.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -88.34 -41.75 12.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -36.83 75.79 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.613 1.551 . . . . 0.0 109.522 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.04 -49.51 15.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -167.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -57.45 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.369 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -57.03 -57.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.327 0.651 . . . . 0.0 109.586 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.3 -48.34 80.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.58 -45.07 73.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.463 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.3 -49.14 76.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.008 0.822 . . . . 0.0 111.652 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -10.05 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.953 0.901 . . . . 0.0 112.65 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -97.11 -60.4 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.433 1.493 . . . . 0.0 109.475 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -49.43 63.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 125.517 1.532 . . . . 0.0 110.85 -170.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -96.22 35.44 1.45 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.861 0.464 . . . . 0.0 110.666 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -152.37 30.33 0.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.124 0.964 . . . . 0.0 110.137 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.07 -41.43 78.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.711 1.604 . . . . 0.0 110.275 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.95 22.6 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.677 1.132 . . . . 0.0 112.744 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.89 -50.91 5.32 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.738 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -60.57 -13.04 5.68 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -32.4 -39.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.082 2.153 . . . . 0.0 111.551 165.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.85 -61.35 5.32 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.985 0.812 . . . . 0.0 112.782 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -67.18 -31.61 72.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.027 1.331 . . . . 0.0 111.563 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -62.19 -45.6 92.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.1 -40.77 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.559 0.744 . . . . 0.0 110.289 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.69 -42.07 27.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.84 -39.25 34.12 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -66.72 -13.49 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 117.424 0.612 . . . . 0.0 111.205 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.25 -40.44 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.771 0.828 . . . . 0.0 110.585 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.42 170.46 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.288 -1.815 . . . . 0.0 110.741 -176.521 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 171.45 -62.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.822 0.849 . . . . 0.0 110.095 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 5' ' ' ARG . 4.2 pt-20 -153.18 178.8 9.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.297 1.039 . . . . 0.0 108.47 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 t80 69.03 -24.75 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.178 1.791 . . . . 0.0 113.659 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 3' ' ' GLU . 45.8 mtp180 -122.54 -52.07 1.93 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.219 2.207 . . . . 0.0 109.316 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -78.15 62.54 2.9 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.185 0.994 . . . . 0.0 108.454 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.52 -64.01 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.741 2.016 . . . . 0.0 105.694 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 m -48.39 -51.42 26.64 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.426 0.557 . . . . 0.0 112.166 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -11.8 74.86 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.305 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -84.26 -49.55 8.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.515 1.158 . . . . 0.0 108.089 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -72.43 -13.98 61.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.169 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' CG1' ' H ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -49.65 -89.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 120.209 1.368 . . . . 0.0 108.429 172.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.438 ' H ' ' CG1' ' A' ' 12' ' ' VAL . 68.6 m80 -49.81 -44.09 49.02 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.816 1.247 . . . . 0.0 111.254 -168.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -35.55 -50.36 0.59 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 112.248 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.11 -19.99 13.16 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.104 0.962 . . . . 0.0 113.512 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -35.68 81.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.71 -50.9 65.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.33 -59.22 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.535 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.84 -50.03 61.68 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 111.486 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -61.93 -51.11 69.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.83 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -60.89 -48.53 81.37 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.803 0.841 . . . . 0.0 112.022 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.82 -53.58 54.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 108.685 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.52 -51.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.686 0.794 . . . . 0.0 110.56 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.78 -50.74 56.9 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.4 m -86.9 29.98 0.78 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.773 0.829 . . . . 0.0 111.85 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -160.29 34.03 0.17 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.853 0.861 . . . . 0.0 111.238 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -56.49 -43.85 80.07 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.786 0.834 . . . . 0.0 109.855 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -42.9 -32.88 1.53 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.822 1.201 . . . . 0.0 112.912 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.18 -48.11 6.35 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.73 0.765 . . . . 0.0 111.279 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.45 -9.81 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.521 0.677 . . . . 0.0 112.565 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.09 159.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.526 1.93 . . . . 0.0 112.929 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.12 -84.03 1.01 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.06 -26.8 67.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 118.139 0.97 . . . . 0.0 112.193 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.79 -27.0 67.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 122.109 -0.369 . . . . 0.0 110.794 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.7 -49.69 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.77 -23.35 75.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.164 1.364 . . . . 0.0 112.429 -170.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.91 -11.64 54.45 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.229 -0.762 . . . . 0.0 111.533 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.89 40.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.188 0.994 . . . . 0.0 108.569 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.1 t -56.67 -50.61 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 110.014 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.58 161.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 C-N-CA 126.435 1.894 . . . . 0.0 108.796 179.55 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.75 -68.21 0.09 Allowed 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.496 0.719 . . . . 0.0 109.418 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.4 -6.57 2.94 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.362 1.065 . . . . 0.0 112.959 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -46.11 -46.09 16.81 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 125.41 1.484 . . . . 0.0 110.239 173.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -68.67 -27.64 66.16 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.288 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -89.09 -135.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.2 t0 57.22 34.41 24.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.892 0.854 . . . . 0.0 109.812 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -69.65 -61.15 1.9 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 126.316 1.846 . . . . 0.0 109.126 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -48.83 -31.48 10.2 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 123.716 0.674 . . . . 0.0 112.649 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -71.93 -64.78 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.06 -0.671 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -44.82 -44.78 9.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.21 1.404 . . . . 0.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -37.18 -62.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 C-N-CA 125.428 1.491 . . . . 0.0 110.906 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -71.01 -45.41 64.02 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -45.46 -43.65 11.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.07 0.856 . . . . 0.0 109.904 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -90.98 -39.23 12.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -29.23 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.972 1.714 . . . . 0.0 109.449 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -10.45 59.4 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.297 0.373 . . . . 0.0 110.192 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.02 -58.86 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.002 1.321 . . . . 0.0 109.384 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -39.74 -55.1 1.99 Allowed 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 126.936 2.094 . . . . 0.0 111.61 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.31 -47.44 85.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.785 0.721 . . . . 0.0 110.371 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.81 90.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.088 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.78 -42.98 99.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.789 0.435 . . . . 0.0 111.955 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.7 -45.28 87.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.461 1.104 . . . . 0.0 108.974 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.04 -57.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.546 0.688 . . . . 0.0 110.358 171.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.39 -47.37 69.26 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.519 1.057 . . . . 0.0 110.638 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -85.84 16.74 3.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.628 0.771 . . . . 0.0 112.763 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -144.51 48.47 1.35 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.556 1.142 . . . . 0.0 109.166 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -52.06 -44.9 64.51 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.1 -31.69 4.53 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.723 1.154 . . . . 0.0 112.834 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.53 -51.76 4.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.726 0.763 . . . . 0.0 111.316 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.73 -2.35 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.866 0.841 . . . . 0.0 112.764 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -36.44 159.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 129.353 3.061 . . . . 0.0 114.85 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.13 -80.01 1.86 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.33 -32.65 72.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.936 0.868 . . . . 0.0 111.962 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -26.76 66.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 122.945 0.498 . . . . 0.0 110.788 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -87.53 -34.78 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.203 0.601 . . . . 0.0 109.97 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.9 -49.58 6.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.94 -26.44 62.36 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.04 0.828 . . . . 0.0 112.253 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.89 -12.36 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 117.521 0.661 . . . . 0.0 111.252 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.73 -35.13 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.36 0.664 . . . . 0.0 111.293 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 mm -102.46 166.35 2.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 C-N-CA 124.67 1.188 . . . . 0.0 111.292 -177.581 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 72.1 -32.83 0.25 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.056 1.742 . . . . 0.0 114.408 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.13 3.64 5.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.863 1.665 . . . . 0.0 111.285 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.1 -52.72 57.85 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -62.44 -51.09 68.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.447 -169.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -61.82 -25.8 67.73 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -87.8 21.9 2.48 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 111.857 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.8 p -44.33 -57.01 3.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.069 1.304 . . . . 0.0 111.631 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.99 -8.06 26.95 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.485 1.041 . . . . 0.0 114.811 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -99.23 -54.94 2.83 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.257 1.423 . . . . 0.0 108.429 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.71 -43.3 26.67 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.724 2.009 . . . . 0.0 111.382 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG1' ' H ' ' A' ' 13' ' ' HIS . 8.7 p -39.51 -72.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 C-N-CA 124.85 1.26 . . . . 0.0 110.999 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.472 ' H ' ' CG1' ' A' ' 12' ' ' VAL . 36.3 m80 -58.25 -47.55 83.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.222 1.009 . . . . 0.0 110.327 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -47.35 -44.99 24.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.927 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -93.77 -35.37 12.8 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -59.83 -30.29 68.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.162 0.985 . . . . 0.0 109.124 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -69.5 -48.21 61.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.98 -51.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.74 -53.14 34.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 0.0 110.765 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.27 -47.96 83.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.227 -0.296 . . . . 0.0 110.355 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.83 -48.9 50.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.272 0.629 . . . . 0.0 109.613 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -51.46 68.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.371 0.668 . . . . 0.0 112.395 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -54.25 -50.16 67.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.763 0.825 . . . . 0.0 109.473 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.73 -55.08 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.871 0.868 . . . . 0.0 110.623 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.91 51.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 m -86.9 28.59 0.88 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.233 1.013 . . . . 0.0 112.227 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -159.94 36.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 112.133 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -55.41 -45.69 76.66 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.077 0.951 . . . . 0.0 109.976 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -43.32 -32.76 1.85 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.959 1.266 . . . . 0.0 112.782 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.2 -48.95 6.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.668 0.734 . . . . 0.0 111.119 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.27 3.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.341 1.067 . . . . 0.0 112.272 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -51.96 162.81 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.574 1.95 . . . . 0.0 112.712 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.15 3.41 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -45.7 81.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 118.25 1.025 . . . . 0.0 109.716 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.7 tpt -53.29 -50.48 64.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.146 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -63.95 -43.56 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.511 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.44 73.3 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.247 1.403 . . . . 0.0 111.294 -172.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -51.73 5.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.9 -19.45 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.627 0.713 . . . . 0.0 112.603 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -51.74 -39.27 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.747 0.819 . . . . 0.0 112.448 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.95 157.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.742 -1.599 . . . . 0.0 109.105 178.476 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.32 68.03 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 109.054 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 66.31 -2.17 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.939 1.696 . . . . 0.0 114.738 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -57.53 -36.14 71.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.571 0.748 . . . . 0.0 111.084 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -64.44 -53.98 39.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.233 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -76.67 43.27 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.656 0.782 . . . . 0.0 112.022 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.48 -73.13 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.271 167.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -55.33 -45.63 76.39 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 118.798 0.726 . . . . 0.0 110.954 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.89 -18.61 54.28 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.956 0.798 . . . . 0.0 113.604 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -88.53 -57.91 2.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.636 1.218 . . . . 0.0 109.205 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -62.58 -22.76 66.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.109 2.163 . . . . 0.0 112.679 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.515 ' CG1' ' H ' ' A' ' 13' ' ' HIS . 5.3 p -51.09 -85.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.653 1.181 . . . . 0.0 109.83 -175.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.515 ' H ' ' CG1' ' A' ' 12' ' ' VAL . 48.7 m80 -51.59 -44.11 62.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 111.313 -175.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -38.57 -41.28 0.66 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.803 0.841 . . . . 0.0 111.487 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.89 -45.98 4.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.49 -40.91 1.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.912 0.885 . . . . 0.0 111.578 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.79 -32.84 65.87 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -172.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.69 -58.54 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -50.22 -54.71 19.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.961 1.305 . . . . 0.0 111.093 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -61.45 -50.37 73.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.073 0.397 . . . . 0.0 110.197 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.81 67.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.145 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.25 -51.12 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.116 0.566 . . . . 0.0 111.704 174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.01 -19.27 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.014 0.926 . . . . 0.0 111.29 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -57.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 109.726 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.02 -50.94 58.76 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.934 1.255 . . . . 0.0 110.358 -169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 m -90.15 32.3 0.94 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.547 0.739 . . . . 0.0 111.351 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -153.45 31.45 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.084 0.945 . . . . 0.0 110.58 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -60.58 -41.08 93.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.955 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.47 -31.15 3.38 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.817 1.198 . . . . 0.0 112.91 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.62 -46.64 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.663 0.731 . . . . 0.0 110.734 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.91 -23.7 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.506 0.67 . . . . 0.0 112.514 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -54.63 168.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.802 2.041 . . . . 0.0 112.515 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.96 -77.0 2.17 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.09 -27.96 69.29 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 117.719 0.76 . . . . 0.0 111.896 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -42.95 99.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.96 -33.57 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.77 -42.01 7.43 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.392 0.996 . . . . 0.0 110.922 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.73 -42.74 93.01 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.31 -19.38 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.884 0.473 . . . . 0.0 111.293 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -47.39 -41.69 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.246 1.018 . . . . 0.0 111.27 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mp -112.92 162.25 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.788 1.635 . . . . 0.0 109.034 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.29 53.05 2.17 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.004 -0.435 . . . . 0.0 110.675 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 62.88 9.69 3.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.606 1.562 . . . . 0.0 112.534 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -64.09 -45.31 89.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -72.82 -49.1 32.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.299 -173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -69.49 -13.11 62.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -59.88 4.31 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.364 0.529 . . . . 0.0 111.143 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -54.25 -49.19 70.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.639 0.2 . . . . 0.0 111.505 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -39.79 48.19 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.609 -0.597 . . . . 0.0 111.609 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -82.31 5.18 20.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -123.99 -49.23 1.85 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 t -40.79 -61.14 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 125.21 1.404 . . . . 0.0 111.544 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -71.09 -43.68 67.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -53.79 -38.13 64.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.217 0.607 . . . . 0.0 109.463 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -86.04 -44.22 12.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -35.29 60.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.396 1.453 . . . . 0.0 109.531 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.268 1.6 pp -77.3 -46.28 23.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.57 -48.33 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.846 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.36 -51.0 71.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.803 1.241 . . . . 0.0 110.004 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.91 -48.06 83.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.75 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.188 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.4 -44.74 86.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.99 -37.16 78.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.03 -53.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.483 0.659 . . . . 0.0 110.678 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.35 94.44 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -172.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.65 31.1 6.41 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.317 -172.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -148.27 39.69 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.431 1.11 . . . . 0.0 109.754 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -58.1 -44.58 87.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.514 -174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.16 -33.09 3.76 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.508 1.051 . . . . 0.0 112.843 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.06 -57.6 3.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.284 0.633 . . . . 0.0 109.375 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -43.35 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 121.18 0.514 . . . . 0.0 111.201 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.8 mt -43.04 -53.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.674 1.99 . . . . 0.0 110.772 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.3 -46.1 72.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.11 -23.49 59.32 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.92 1.288 . . . . 0.0 112.302 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -51.72 65.86 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 t -65.96 -47.1 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.039 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.84 -32.99 63.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.027 0.822 . . . . 0.0 111.499 -170.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.38 -36.87 15.97 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.0 34.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.098 0.952 . . . . 0.0 109.351 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -56.1 -42.84 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.465 1.106 . . . . 0.0 111.335 173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.04 166.19 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.125 1.37 . . . . 0.0 111.278 -177.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.36 -82.64 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.232 0.613 . . . . 0.0 109.356 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -154.79 39.05 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.467 1.907 . . . . 0.0 107.209 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -98.39 -23.22 15.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.284 0.633 . . . . 0.0 110.593 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -105.57 -49.08 3.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.907 0.883 . . . . 0.0 112.031 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -75.65 1.98 13.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.652 -0.655 . . . . 0.0 112.644 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -73.72 25.42 0.07 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.692 -1.255 . . . . 0.0 113.699 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 m -57.65 -48.51 79.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.485 1.039 . . . . 0.0 110.473 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -16.58 56.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.362 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -90.24 -57.71 2.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.246 1.019 . . . . 0.0 108.817 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -62.03 -29.36 70.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.896 1.278 . . . . 0.0 113.225 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' CG1' ' H ' ' A' ' 13' ' ' HIS . 6.1 p -41.73 -63.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.566 1.146 . . . . 0.0 111.427 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.438 ' H ' ' CG1' ' A' ' 12' ' ' VAL . 47.8 m80 -65.37 -46.71 79.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.522 1.129 . . . . 0.0 110.173 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.89 -45.1 10.13 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 123.436 0.46 . . . . 0.0 109.981 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.253 24.6 pt20 -86.86 -50.67 6.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.78 -36.37 16.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.612 1.551 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -25.02 55.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -171.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -89.96 -52.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.46 1.104 . . . . 0.0 109.524 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -48.32 -52.0 23.54 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.65 1.98 . . . . 0.0 109.952 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -58.12 -50.36 73.76 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.235 0.925 . . . . 0.0 110.744 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -49.52 65.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -56.96 -46.96 81.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.186 0.594 . . . . 0.0 112.465 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -8.55 48.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.604 1.162 . . . . 0.0 112.053 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.78 -57.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.847 1.259 . . . . 0.0 108.556 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.7 -56.56 15.31 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.295 1.426 . . . . 0.0 110.911 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 m -84.88 21.87 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.631 0.772 . . . . 0.0 112.446 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -140.75 32.58 1.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.036 1.335 . . . . 0.0 109.049 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -42.55 91.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.83 0.852 . . . . 0.0 109.703 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.96 -27.76 22.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.597 1.094 . . . . 0.0 112.963 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.48 -51.64 5.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.956 0.878 . . . . 0.0 110.165 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mp -65.52 -10.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.488 0.715 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -33.04 -47.44 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 127.993 2.517 . . . . 0.0 113.667 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.53 -52.56 40.71 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.48 -27.22 64.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.122 1.369 . . . . 0.0 112.36 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttp -62.45 -53.68 51.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.68 -35.45 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.908 0.883 . . . . 0.0 110.711 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.21 -49.8 6.65 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.38 -37.68 95.02 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.66 -14.85 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.289 0.544 . . . . 0.0 111.547 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.64 -37.55 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 123.034 0.534 . . . . 0.0 110.925 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -107.82 167.01 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.65 1.18 . . . . 0.0 111.255 -177.234 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.75 103.03 0.07 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.602 1.561 . . . . 0.0 111.851 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 66.66 3.64 3.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.866 1.666 . . . . 0.0 113.929 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.3 -39.64 92.77 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -79.83 -33.4 40.3 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.487 1.515 . . . . 0.0 111.266 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -95.06 -128.15 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 t70 57.98 23.51 10.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 110.982 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -72.74 -55.77 6.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.641 1.177 . . . . 0.0 110.015 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.36 -4.72 9.41 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.323 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -93.5 -58.8 2.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.728 1.264 . . . . 0.0 109.064 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -55.28 -30.41 60.08 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.064 0.946 . . . . 0.0 111.987 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.524 ' CG1' ' H ' ' A' ' 13' ' ' HIS . 7.5 p -38.04 -77.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 C-N-CA 125.477 1.511 . . . . 0.0 112.506 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.524 ' H ' ' CG1' ' A' ' 12' ' ' VAL . 38.0 m80 -67.1 -41.12 86.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -42.89 -44.41 4.53 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 12.9 pt20 -92.67 -39.79 11.09 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.09 66.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 120.003 1.274 . . . . 0.0 109.91 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -16.97 61.11 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.917 -0.489 . . . . 0.0 109.94 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.3 -62.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.304 1.041 . . . . 0.0 109.241 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.88 -47.07 78.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.298 1.439 . . . . 0.0 111.158 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.18 -48.33 73.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.008 0.822 . . . . 0.0 109.472 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.89 72.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.217 0.607 . . . . 0.0 110.922 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.02 -50.47 70.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.716 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -51.99 65.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -58.51 -56.08 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.492 0.717 . . . . 0.0 110.193 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.45 -55.04 30.54 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 m -82.75 17.4 1.86 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -144.02 39.71 1.35 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.345 1.058 . . . . 0.0 108.85 169.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -54.65 -44.17 73.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.779 0.831 . . . . 0.0 110.008 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.89 -26.91 27.74 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.566 1.079 . . . . 0.0 113.14 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.96 -53.6 4.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.158 0.979 . . . . 0.0 110.193 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.79 -5.25 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.529 0.732 . . . . 0.0 112.385 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -32.5 -43.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 127.756 2.422 . . . . 0.0 112.052 169.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.12 -54.38 4.53 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.615 0.643 . . . . 0.0 112.777 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -38.99 84.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.426 1.09 . . . . 0.0 110.442 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -56.52 -45.64 80.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.1 t -72.53 -43.01 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.41 97.27 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.62 -33.2 66.5 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.2 t -72.68 -10.77 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 122.876 0.471 . . . . 0.0 110.577 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.01 -43.88 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 O-C-N 121.521 -0.737 . . . . 0.0 111.169 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.2 mt -108.19 173.63 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 116.502 -1.713 . . . . 0.0 111.101 -179.116 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 119.892 -0.099 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.67 -63.24 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.36 0.664 . . . . 0.0 109.656 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 5' ' ' ARG . 2.6 mt-10 -155.89 -179.93 8.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 t80 65.97 -12.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 115.034 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 3' ' ' GLU . 56.8 mtt180 -130.77 -48.29 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.618 1.967 . . . . 0.0 108.9 166.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -55.69 -35.16 65.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.291 1.036 . . . . 0.0 112.789 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -98.95 -53.11 3.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.896 1.278 . . . . 0.0 110.774 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 p -54.63 -42.19 70.91 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.598 -0.715 . . . . 0.0 110.022 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -45.54 -36.24 5.96 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.141 0.882 . . . . 0.0 112.648 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -71.22 -70.79 0.29 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -49.9 -39.9 41.35 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.097 0.959 . . . . 0.0 113.364 -170.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -36.22 -64.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 C-N-CA 125.961 1.705 . . . . 0.0 109.837 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -70.14 -45.94 65.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -41.89 -39.94 1.97 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.35 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -101.33 -43.45 5.95 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -35.65 65.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.985 1.266 . . . . 0.0 108.633 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.14 -16.34 61.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.3 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.68 -53.47 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.609 1.163 . . . . 0.0 109.911 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -52.65 -49.46 65.15 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.724 1.61 . . . . 0.0 110.316 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.57 -47.16 87.4 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.586 0.63 . . . . 0.0 109.852 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.84 83.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.574 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -58.73 -49.73 76.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.96 0.504 . . . . 0.0 111.672 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -29.31 69.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.531 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.82 -56.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.41 0.624 . . . . 0.0 110.253 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.62 -49.78 67.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.65 1.119 . . . . 0.0 110.767 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -102.25 36.55 2.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.918 0.887 . . . . 0.0 111.027 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -153.46 37.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.811 0.815 . . . . 0.0 110.097 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -56.46 -43.9 80.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.685 -0.634 . . . . 0.0 109.931 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.33 -29.58 2.57 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.518 1.056 . . . . 0.0 113.316 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.56 7.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.944 0.898 . . . . 0.0 110.939 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.82 -27.15 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.568 0.699 . . . . 0.0 112.387 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.74 167.72 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.861 2.064 . . . . 0.0 112.114 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.27 -75.95 2.28 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.64 -27.28 68.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 117.682 0.741 . . . . 0.0 112.185 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -67.65 -34.37 76.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.95 -35.54 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.681 0.792 . . . . 0.0 110.138 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.29 -49.02 7.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.76 -27.42 71.08 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.604 -0.939 . . . . 0.0 111.822 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.78 -5.6 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 117.93 0.865 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.26 -51.57 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.42 -0.8 . . . . 0.0 109.497 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.0 tt -68.72 153.72 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.846 0.832 . . . . 0.0 111.216 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 128.065 2.546 . . . . 0.0 112.025 -177.424 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.95 -37.62 0.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.582 1.537 . . . . 0.0 111.719 169.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.75 -50.94 62.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.27 -55.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.095 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -52.66 -53.29 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.223 1.409 . . . . 0.0 111.586 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -62.96 -47.2 84.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.66 78.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.988 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -59.18 -53.44 58.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.78 0.832 . . . . 0.0 110.057 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.16 -48.24 71.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.342 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.47 -49.62 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.355 0.598 . . . . 0.0 111.072 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -53.84 41.21 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 123.329 0.651 . . . . 0.0 112.024 177.3 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -36.83 75.79 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.613 1.551 . . . . 0.0 109.522 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.04 -49.51 15.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -167.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -57.45 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.369 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -57.03 -57.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.327 0.651 . . . . 0.0 109.586 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.3 -48.34 80.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.58 -45.07 73.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.463 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.3 -49.14 76.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.008 0.822 . . . . 0.0 111.652 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -10.05 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.953 0.901 . . . . 0.0 112.65 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -97.11 -60.4 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.433 1.493 . . . . 0.0 109.475 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -49.43 63.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 125.517 1.532 . . . . 0.0 110.85 -170.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 122.861 0.464 . . . . 0.0 110.666 -179.316 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -35.68 81.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.71 -50.9 65.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.33 -59.22 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.535 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.84 -50.03 61.68 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 111.486 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -61.93 -51.11 69.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.83 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -60.89 -48.53 81.37 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.803 0.841 . . . . 0.0 112.022 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.82 -53.58 54.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 108.685 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.52 -51.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.686 0.794 . . . . 0.0 110.56 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.78 -50.74 56.9 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.4 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 123.773 0.829 . . . . 0.0 111.85 179.442 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -29.23 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.972 1.714 . . . . 0.0 109.449 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -10.45 59.4 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.297 0.373 . . . . 0.0 110.192 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.02 -58.86 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.002 1.321 . . . . 0.0 109.384 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -39.74 -55.1 1.99 Allowed 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 126.936 2.094 . . . . 0.0 111.61 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.31 -47.44 85.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.785 0.721 . . . . 0.0 110.371 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.81 90.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.088 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.78 -42.98 99.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.789 0.435 . . . . 0.0 111.955 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.7 -45.28 87.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.461 1.104 . . . . 0.0 108.974 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.04 -57.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.546 0.688 . . . . 0.0 110.358 171.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.39 -47.37 69.26 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.519 1.057 . . . . 0.0 110.638 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.451 -0.377 0 C-N-CA 123.628 0.771 . . . . 0.0 112.763 -176.811 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -59.83 -30.29 68.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.162 0.985 . . . . 0.0 109.124 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -69.5 -48.21 61.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.98 -51.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.74 -53.14 34.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 0.0 110.765 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.27 -47.96 83.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.227 -0.296 . . . . 0.0 110.355 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.83 -48.9 50.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.272 0.629 . . . . 0.0 109.613 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -51.46 68.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.371 0.668 . . . . 0.0 112.395 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -54.25 -50.16 67.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.763 0.825 . . . . 0.0 109.473 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.73 -55.08 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.871 0.868 . . . . 0.0 110.623 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.91 51.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 124.233 1.013 . . . . 0.0 112.227 179.596 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.49 -40.91 1.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.912 0.885 . . . . 0.0 111.578 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.79 -32.84 65.87 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -172.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.69 -58.54 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -50.22 -54.71 19.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.961 1.305 . . . . 0.0 111.093 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -61.45 -50.37 73.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.073 0.397 . . . . 0.0 110.197 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.81 67.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.145 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.25 -51.12 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.116 0.566 . . . . 0.0 111.704 174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.01 -19.27 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.014 0.926 . . . . 0.0 111.29 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -57.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 109.726 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.02 -50.94 58.76 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.934 1.255 . . . . 0.0 110.358 -169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 123.547 0.739 . . . . 0.0 111.351 179.379 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -35.29 60.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.396 1.453 . . . . 0.0 109.531 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.268 1.6 pp -77.3 -46.28 23.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.57 -48.33 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.846 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.36 -51.0 71.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.803 1.241 . . . . 0.0 110.004 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.91 -48.06 83.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.75 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.188 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.4 -44.74 86.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.99 -37.16 78.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.03 -53.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.483 0.659 . . . . 0.0 110.678 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.35 94.44 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -172.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.317 -172.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.253 24.6 pt20 . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.78 -36.37 16.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.612 1.551 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -25.02 55.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -171.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -89.96 -52.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.46 1.104 . . . . 0.0 109.524 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -48.32 -52.0 23.54 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.65 1.98 . . . . 0.0 109.952 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -58.12 -50.36 73.76 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.235 0.925 . . . . 0.0 110.744 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -49.52 65.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -56.96 -46.96 81.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.186 0.594 . . . . 0.0 112.465 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -8.55 48.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.604 1.162 . . . . 0.0 112.053 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.78 -57.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.847 1.259 . . . . 0.0 108.556 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.7 -56.56 15.31 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.295 1.426 . . . . 0.0 110.911 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.452 -0.354 0 C-N-CA 123.631 0.772 . . . . 0.0 112.446 -177.201 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 12.9 pt20 . . . . . 0 N--CA 1.445 -0.725 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.09 66.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 120.003 1.274 . . . . 0.0 109.91 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -16.97 61.11 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.917 -0.489 . . . . 0.0 109.94 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.3 -62.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.304 1.041 . . . . 0.0 109.241 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.88 -47.07 78.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.298 1.439 . . . . 0.0 111.158 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.18 -48.33 73.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.008 0.822 . . . . 0.0 109.472 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.89 72.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.217 0.607 . . . . 0.0 110.922 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.02 -50.47 70.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.716 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -51.99 65.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -58.51 -56.08 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.492 0.717 . . . . 0.0 110.193 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.45 -55.04 30.54 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.851 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -35.65 65.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.985 1.266 . . . . 0.0 108.633 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.14 -16.34 61.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.3 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.68 -53.47 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.609 1.163 . . . . 0.0 109.911 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -52.65 -49.46 65.15 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.724 1.61 . . . . 0.0 110.316 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.57 -47.16 87.4 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.586 0.63 . . . . 0.0 109.852 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.84 83.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.574 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -58.73 -49.73 76.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.96 0.504 . . . . 0.0 111.672 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -29.31 69.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.531 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.82 -56.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.41 0.624 . . . . 0.0 110.253 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.62 -49.78 67.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.65 1.119 . . . . 0.0 110.767 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 123.918 0.887 . . . . 0.0 111.027 -176.388 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.2 -72.13 0.18 Allowed 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.406 0.683 . . . . 0.0 109.262 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -140.05 5.11 2.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.506 0.722 . . . . 0.0 112.815 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.98 -33.71 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.402 0.681 . . . . 0.0 110.56 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -75.56 -57.16 4.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.919 0.888 . . . . 0.0 110.941 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -77.87 58.42 1.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.748 0.819 . . . . 0.0 111.657 -170.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.38 -60.46 1.52 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 109.853 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -53.4 -51.21 63.28 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.9 -0.5 . . . . 0.0 110.732 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.36 -14.73 57.74 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.836 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.33 -54.74 4.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.024 1.412 . . . . 0.0 108.566 171.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.91 -30.2 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.138 1.375 . . . . 0.0 112.94 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.73 HG13 ' H ' ' A' ' 13' ' ' HIS . 3.9 p -44.31 -80.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.147 0.979 . . . . 0.0 110.879 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.73 ' H ' HG13 ' A' ' 12' ' ' VAL . 48.9 m80 -58.92 -39.69 82.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.867 0.867 . . . . 0.0 110.812 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -44.49 -37.74 3.68 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.414 0.446 . . . . 0.0 110.298 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -98.21 -52.7 3.59 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.95 -37.62 0.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.582 1.537 . . . . 0.0 111.719 169.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.75 -50.94 62.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.27 -55.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.095 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -52.66 -53.29 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.223 1.409 . . . . 0.0 111.586 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -62.96 -47.2 84.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.66 78.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.988 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -59.18 -53.44 58.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.78 0.832 . . . . 0.0 110.057 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.16 -48.24 71.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.342 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.47 -49.62 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.355 0.598 . . . . 0.0 111.072 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -53.84 41.21 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 m -81.26 30.11 0.34 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.329 0.651 . . . . 0.0 112.024 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -156.6 32.36 0.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.176 0.99 . . . . 0.0 110.394 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -58.4 -39.39 79.57 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.74 0.816 . . . . 0.0 109.834 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.44 -31.75 5.05 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.028 0.823 . . . . 0.0 112.353 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.54 -54.23 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.521 0.661 . . . . 0.0 110.489 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.257 2.0 mp -64.56 -10.46 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -31.51 -41.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 127.9 2.48 . . . . 0.0 112.657 167.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.56 -53.57 12.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.571 0.623 . . . . 0.0 112.067 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.85 -41.0 83.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.402 1.081 . . . . 0.0 109.862 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -54.88 -51.15 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.01 -44.64 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.349 0.66 . . . . 0.0 109.598 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.38 -27.97 61.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.436 1.017 . . . . 0.0 111.63 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.5 -16.6 48.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.511 1.053 . . . . 0.0 112.52 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.65 -36.37 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.708 1.254 . . . . 0.0 110.228 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.12 -40.0 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 42' ' ' ALA . 1.6 mp -96.44 176.88 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 41' ' ' ILE . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.7 -1.619 . . . . 0.0 111.322 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.34 -63.58 0.38 Allowed 'General case' 0 C--N 1.338 0.093 0 C-N-CA 126.21 1.804 . . . . 0.0 111.718 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -105.59 157.09 17.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.8 t80 77.83 -50.41 0.51 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.998 1.719 . . . . 0.0 110.675 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -32.96 72.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.106 0.962 . . . . 0.0 110.947 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.79 -25.61 55.89 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.37 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.37 31.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.149 1.779 . . . . 0.0 113.347 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m -52.79 -50.05 64.37 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.84 1.2 . . . . 0.0 111.067 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.35 70.63 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 -62.01 1.7 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -48.05 -33.49 8.12 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 127.205 2.202 . . . . 0.0 112.467 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -46.18 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.329 1.052 . . . . 0.0 110.7 172.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -77.63 -41.56 38.0 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 122.905 0.482 . . . . 0.0 110.188 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -49.69 -46.38 49.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -88.34 -41.75 12.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -36.83 75.79 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.613 1.551 . . . . 0.0 109.522 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.04 -49.51 15.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -167.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -57.45 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.369 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -57.03 -57.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.327 0.651 . . . . 0.0 109.586 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.3 -48.34 80.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.58 -45.07 73.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.463 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.3 -49.14 76.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.008 0.822 . . . . 0.0 111.652 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -10.05 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.953 0.901 . . . . 0.0 112.65 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -97.11 -60.4 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.433 1.493 . . . . 0.0 109.475 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -49.43 63.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 125.517 1.532 . . . . 0.0 110.85 -170.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -96.22 35.44 1.45 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.861 0.464 . . . . 0.0 110.666 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -152.37 30.33 0.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.124 0.964 . . . . 0.0 110.137 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.07 -41.43 78.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.711 1.604 . . . . 0.0 110.275 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.95 22.6 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.677 1.132 . . . . 0.0 112.744 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.89 -50.91 5.32 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.738 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -60.57 -13.04 5.68 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -32.4 -39.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.082 2.153 . . . . 0.0 111.551 165.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.85 -61.35 5.32 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.985 0.812 . . . . 0.0 112.782 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -67.18 -31.61 72.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.027 1.331 . . . . 0.0 111.563 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -62.19 -45.6 92.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.1 -40.77 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.559 0.744 . . . . 0.0 110.289 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.69 -42.07 27.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.84 -39.25 34.12 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -66.72 -13.49 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 117.424 0.612 . . . . 0.0 111.205 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.25 -40.44 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.771 0.828 . . . . 0.0 110.585 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 42' ' ' ALA . 1.5 mp -108.42 170.46 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 41' ' ' ILE . . . . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.288 -1.815 . . . . 0.0 110.741 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 171.45 -62.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.822 0.849 . . . . 0.0 110.095 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -153.18 178.8 9.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.297 1.039 . . . . 0.0 108.47 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 t80 69.03 -24.75 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.178 1.791 . . . . 0.0 113.659 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -122.54 -52.07 1.93 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.219 2.207 . . . . 0.0 109.316 169.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -78.15 62.54 2.9 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.185 0.994 . . . . 0.0 108.454 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.52 -64.01 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.741 2.016 . . . . 0.0 105.694 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 m -48.39 -51.42 26.64 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.426 0.557 . . . . 0.0 112.166 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -11.8 74.86 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.305 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -84.26 -49.55 8.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.515 1.158 . . . . 0.0 108.089 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -72.43 -13.98 61.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.169 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG13 ' H ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -49.65 -89.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 120.209 1.368 . . . . 0.0 108.429 172.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.642 ' H ' HG13 ' A' ' 12' ' ' VAL . 68.6 m80 -49.81 -44.09 49.02 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.816 1.247 . . . . 0.0 111.254 -168.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -35.55 -50.36 0.59 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 112.248 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.11 -19.99 13.16 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.104 0.962 . . . . 0.0 113.512 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -35.68 81.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.71 -50.9 65.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.33 -59.22 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.535 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.84 -50.03 61.68 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 111.486 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -61.93 -51.11 69.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.83 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -60.89 -48.53 81.37 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.803 0.841 . . . . 0.0 112.022 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.82 -53.58 54.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 108.685 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.52 -51.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.686 0.794 . . . . 0.0 110.56 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.78 -50.74 56.9 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.4 m -86.9 29.98 0.78 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.773 0.829 . . . . 0.0 111.85 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -160.29 34.03 0.17 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.853 0.861 . . . . 0.0 111.238 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -56.49 -43.85 80.07 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.786 0.834 . . . . 0.0 109.855 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -42.9 -32.88 1.53 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.822 1.201 . . . . 0.0 112.912 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.18 -48.11 6.35 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.73 0.765 . . . . 0.0 111.279 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.45 -9.81 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.521 0.677 . . . . 0.0 112.565 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.09 159.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.526 1.93 . . . . 0.0 112.929 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.12 -84.03 1.01 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.06 -26.8 67.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 118.139 0.97 . . . . 0.0 112.193 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.79 -27.0 67.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 122.109 -0.369 . . . . 0.0 110.794 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.7 -49.69 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.77 -23.35 75.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.164 1.364 . . . . 0.0 112.429 -170.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.91 -11.64 54.45 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.229 -0.762 . . . . 0.0 111.533 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.89 40.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.188 0.994 . . . . 0.0 108.569 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.1 t -56.67 -50.61 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 110.014 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.58 161.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 C-N-CA 126.435 1.894 . . . . 0.0 108.796 179.55 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.75 -68.21 0.09 Allowed 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.496 0.719 . . . . 0.0 109.418 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.4 -6.57 2.94 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.362 1.065 . . . . 0.0 112.959 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -46.11 -46.09 16.81 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 125.41 1.484 . . . . 0.0 110.239 173.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -68.67 -27.64 66.16 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.288 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -89.09 -135.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.2 t0 57.22 34.41 24.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.892 0.854 . . . . 0.0 109.812 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -69.65 -61.15 1.9 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 126.316 1.846 . . . . 0.0 109.126 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -48.83 -31.48 10.2 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 123.716 0.674 . . . . 0.0 112.649 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -71.93 -64.78 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.06 -0.671 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -44.82 -44.78 9.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.21 1.404 . . . . 0.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -37.18 -62.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 C-N-CA 125.428 1.491 . . . . 0.0 110.906 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -71.01 -45.41 64.02 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -45.46 -43.65 11.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.07 0.856 . . . . 0.0 109.904 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -90.98 -39.23 12.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -29.23 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.972 1.714 . . . . 0.0 109.449 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -10.45 59.4 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.297 0.373 . . . . 0.0 110.192 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.02 -58.86 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.002 1.321 . . . . 0.0 109.384 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -39.74 -55.1 1.99 Allowed 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 126.936 2.094 . . . . 0.0 111.61 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.31 -47.44 85.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.785 0.721 . . . . 0.0 110.371 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.81 90.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.088 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.78 -42.98 99.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.789 0.435 . . . . 0.0 111.955 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.7 -45.28 87.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.461 1.104 . . . . 0.0 108.974 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.04 -57.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.546 0.688 . . . . 0.0 110.358 171.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.39 -47.37 69.26 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.519 1.057 . . . . 0.0 110.638 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -85.84 16.74 3.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.628 0.771 . . . . 0.0 112.763 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -144.51 48.47 1.35 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.556 1.142 . . . . 0.0 109.166 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -52.06 -44.9 64.51 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.1 -31.69 4.53 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.723 1.154 . . . . 0.0 112.834 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.53 -51.76 4.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.726 0.763 . . . . 0.0 111.316 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.73 -2.35 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.866 0.841 . . . . 0.0 112.764 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -36.44 159.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 129.353 3.061 . . . . 0.0 114.85 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.13 -80.01 1.86 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.33 -32.65 72.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.936 0.868 . . . . 0.0 111.962 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -26.76 66.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 122.945 0.498 . . . . 0.0 110.788 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -87.53 -34.78 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.203 0.601 . . . . 0.0 109.97 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.9 -49.58 6.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.94 -26.44 62.36 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.04 0.828 . . . . 0.0 112.253 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.89 -12.36 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 117.521 0.661 . . . . 0.0 111.252 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.73 -35.13 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.36 0.664 . . . . 0.0 111.293 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 mm -102.46 166.35 2.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 C-N-CA 124.67 1.188 . . . . 0.0 111.292 -177.581 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 72.1 -32.83 0.25 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.056 1.742 . . . . 0.0 114.408 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.13 3.64 5.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.863 1.665 . . . . 0.0 111.285 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.1 -52.72 57.85 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -62.44 -51.09 68.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.447 -169.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -61.82 -25.8 67.73 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -87.8 21.9 2.48 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 111.857 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.8 p -44.33 -57.01 3.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.069 1.304 . . . . 0.0 111.631 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.99 -8.06 26.95 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.485 1.041 . . . . 0.0 114.811 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -99.23 -54.94 2.83 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.257 1.423 . . . . 0.0 108.429 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.71 -43.3 26.67 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.724 2.009 . . . . 0.0 111.382 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 13' ' ' HIS . 8.7 p -39.51 -72.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 C-N-CA 124.85 1.26 . . . . 0.0 110.999 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.648 ' H ' HG13 ' A' ' 12' ' ' VAL . 36.3 m80 -58.25 -47.55 83.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.222 1.009 . . . . 0.0 110.327 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -47.35 -44.99 24.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.927 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -93.77 -35.37 12.8 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -59.83 -30.29 68.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.162 0.985 . . . . 0.0 109.124 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -69.5 -48.21 61.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.98 -51.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.74 -53.14 34.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 0.0 110.765 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.27 -47.96 83.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.227 -0.296 . . . . 0.0 110.355 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.83 -48.9 50.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.272 0.629 . . . . 0.0 109.613 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -51.46 68.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.371 0.668 . . . . 0.0 112.395 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -54.25 -50.16 67.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.763 0.825 . . . . 0.0 109.473 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.73 -55.08 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.871 0.868 . . . . 0.0 110.623 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.91 51.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 m -86.9 28.59 0.88 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.233 1.013 . . . . 0.0 112.227 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -159.94 36.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 112.133 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -55.41 -45.69 76.66 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.077 0.951 . . . . 0.0 109.976 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -43.32 -32.76 1.85 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.959 1.266 . . . . 0.0 112.782 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.2 -48.95 6.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.668 0.734 . . . . 0.0 111.119 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.27 3.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.341 1.067 . . . . 0.0 112.272 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -51.96 162.81 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.574 1.95 . . . . 0.0 112.712 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.15 3.41 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -45.7 81.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 118.25 1.025 . . . . 0.0 109.716 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.7 tpt -53.29 -50.48 64.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.146 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -63.95 -43.56 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.511 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.44 73.3 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.247 1.403 . . . . 0.0 111.294 -172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -51.73 5.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.9 -19.45 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.627 0.713 . . . . 0.0 112.603 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -51.74 -39.27 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.747 0.819 . . . . 0.0 112.448 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.95 157.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.742 -1.599 . . . . 0.0 109.105 178.476 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.32 68.03 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 109.054 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 66.31 -2.17 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.939 1.696 . . . . 0.0 114.738 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -57.53 -36.14 71.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.571 0.748 . . . . 0.0 111.084 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -64.44 -53.98 39.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.233 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -76.67 43.27 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.656 0.782 . . . . 0.0 112.022 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.48 -73.13 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.271 167.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -55.33 -45.63 76.39 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 118.798 0.726 . . . . 0.0 110.954 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.89 -18.61 54.28 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.956 0.798 . . . . 0.0 113.604 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -88.53 -57.91 2.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.636 1.218 . . . . 0.0 109.205 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -62.58 -22.76 66.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.109 2.163 . . . . 0.0 112.679 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.763 HG13 ' H ' ' A' ' 13' ' ' HIS . 5.3 p -51.09 -85.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.653 1.181 . . . . 0.0 109.83 -175.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.763 ' H ' HG13 ' A' ' 12' ' ' VAL . 48.7 m80 -51.59 -44.11 62.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 111.313 -175.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -38.57 -41.28 0.66 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.803 0.841 . . . . 0.0 111.487 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.89 -45.98 4.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.49 -40.91 1.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.912 0.885 . . . . 0.0 111.578 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.79 -32.84 65.87 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -172.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.69 -58.54 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -50.22 -54.71 19.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.961 1.305 . . . . 0.0 111.093 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -61.45 -50.37 73.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.073 0.397 . . . . 0.0 110.197 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.81 67.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.145 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.25 -51.12 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.116 0.566 . . . . 0.0 111.704 174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.01 -19.27 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.014 0.926 . . . . 0.0 111.29 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -57.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 109.726 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.02 -50.94 58.76 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.934 1.255 . . . . 0.0 110.358 -169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 m -90.15 32.3 0.94 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.547 0.739 . . . . 0.0 111.351 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -153.45 31.45 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.084 0.945 . . . . 0.0 110.58 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -60.58 -41.08 93.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.955 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.47 -31.15 3.38 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.817 1.198 . . . . 0.0 112.91 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.62 -46.64 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.663 0.731 . . . . 0.0 110.734 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.91 -23.7 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.506 0.67 . . . . 0.0 112.514 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -54.63 168.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.802 2.041 . . . . 0.0 112.515 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.96 -77.0 2.17 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.09 -27.96 69.29 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 117.719 0.76 . . . . 0.0 111.896 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -42.95 99.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.96 -33.57 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.77 -42.01 7.43 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.392 0.996 . . . . 0.0 110.922 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.73 -42.74 93.01 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.31 -19.38 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.884 0.473 . . . . 0.0 111.293 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -47.39 -41.69 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.246 1.018 . . . . 0.0 111.27 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mp -112.92 162.25 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.788 1.635 . . . . 0.0 109.034 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.29 53.05 2.17 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.004 -0.435 . . . . 0.0 110.675 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 62.88 9.69 3.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.606 1.562 . . . . 0.0 112.534 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -64.09 -45.31 89.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -72.82 -49.1 32.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.299 -173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -69.49 -13.11 62.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -59.88 4.31 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.364 0.529 . . . . 0.0 111.143 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -54.25 -49.19 70.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.639 0.2 . . . . 0.0 111.505 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -39.79 48.19 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.609 -0.597 . . . . 0.0 111.609 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -82.31 5.18 20.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -123.99 -49.23 1.85 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 t -40.79 -61.14 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 125.21 1.404 . . . . 0.0 111.544 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -71.09 -43.68 67.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -53.79 -38.13 64.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.217 0.607 . . . . 0.0 109.463 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -86.04 -44.22 12.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -35.29 60.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.396 1.453 . . . . 0.0 109.531 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.268 1.6 pp -77.3 -46.28 23.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.57 -48.33 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.846 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.36 -51.0 71.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.803 1.241 . . . . 0.0 110.004 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.91 -48.06 83.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.75 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.188 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.4 -44.74 86.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.99 -37.16 78.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.03 -53.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.483 0.659 . . . . 0.0 110.678 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.35 94.44 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -172.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.65 31.1 6.41 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.317 -172.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -148.27 39.69 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.431 1.11 . . . . 0.0 109.754 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -58.1 -44.58 87.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.514 -174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.16 -33.09 3.76 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.508 1.051 . . . . 0.0 112.843 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.06 -57.6 3.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.284 0.633 . . . . 0.0 109.375 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -43.35 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 121.18 0.514 . . . . 0.0 111.201 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.8 mt -43.04 -53.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.674 1.99 . . . . 0.0 110.772 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.3 -46.1 72.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.11 -23.49 59.32 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.92 1.288 . . . . 0.0 112.302 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -51.72 65.86 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 t -65.96 -47.1 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.039 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.84 -32.99 63.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.027 0.822 . . . . 0.0 111.499 -170.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.38 -36.87 15.97 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.0 34.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.098 0.952 . . . . 0.0 109.351 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -56.1 -42.84 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.465 1.106 . . . . 0.0 111.335 173.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.04 166.19 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.125 1.37 . . . . 0.0 111.278 -177.985 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.36 -82.64 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.232 0.613 . . . . 0.0 109.356 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -154.79 39.05 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.467 1.907 . . . . 0.0 107.209 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -98.39 -23.22 15.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.284 0.633 . . . . 0.0 110.593 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -105.57 -49.08 3.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.907 0.883 . . . . 0.0 112.031 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -75.65 1.98 13.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.652 -0.655 . . . . 0.0 112.644 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -73.72 25.42 0.07 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.692 -1.255 . . . . 0.0 113.699 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 m -57.65 -48.51 79.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.485 1.039 . . . . 0.0 110.473 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -16.58 56.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.362 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -90.24 -57.71 2.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.246 1.019 . . . . 0.0 108.817 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -62.03 -29.36 70.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.896 1.278 . . . . 0.0 113.225 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.559 HG13 ' H ' ' A' ' 13' ' ' HIS . 6.1 p -41.73 -63.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.566 1.146 . . . . 0.0 111.427 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.559 ' H ' HG13 ' A' ' 12' ' ' VAL . 47.8 m80 -65.37 -46.71 79.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.522 1.129 . . . . 0.0 110.173 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.89 -45.1 10.13 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 123.436 0.46 . . . . 0.0 109.981 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.253 24.6 pt20 -86.86 -50.67 6.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.78 -36.37 16.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.612 1.551 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -25.02 55.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -171.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -89.96 -52.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.46 1.104 . . . . 0.0 109.524 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -48.32 -52.0 23.54 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.65 1.98 . . . . 0.0 109.952 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -58.12 -50.36 73.76 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.235 0.925 . . . . 0.0 110.744 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -49.52 65.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -56.96 -46.96 81.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.186 0.594 . . . . 0.0 112.465 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -8.55 48.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.604 1.162 . . . . 0.0 112.053 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.78 -57.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.847 1.259 . . . . 0.0 108.556 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.7 -56.56 15.31 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.295 1.426 . . . . 0.0 110.911 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 m -84.88 21.87 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.631 0.772 . . . . 0.0 112.446 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -140.75 32.58 1.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.036 1.335 . . . . 0.0 109.049 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -42.55 91.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.83 0.852 . . . . 0.0 109.703 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.96 -27.76 22.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.597 1.094 . . . . 0.0 112.963 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.48 -51.64 5.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.956 0.878 . . . . 0.0 110.165 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mp -65.52 -10.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.488 0.715 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -33.04 -47.44 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 127.993 2.517 . . . . 0.0 113.667 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.53 -52.56 40.71 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.48 -27.22 64.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.122 1.369 . . . . 0.0 112.36 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttp -62.45 -53.68 51.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.68 -35.45 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.908 0.883 . . . . 0.0 110.711 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.21 -49.8 6.65 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.38 -37.68 95.02 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.66 -14.85 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.289 0.544 . . . . 0.0 111.547 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.64 -37.55 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 123.034 0.534 . . . . 0.0 110.925 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -107.82 167.01 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.65 1.18 . . . . 0.0 111.255 -177.234 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.75 103.03 0.07 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.602 1.561 . . . . 0.0 111.851 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 66.66 3.64 3.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.866 1.666 . . . . 0.0 113.929 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.3 -39.64 92.77 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -79.83 -33.4 40.3 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.487 1.515 . . . . 0.0 111.266 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -95.06 -128.15 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 t70 57.98 23.51 10.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 110.982 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -72.74 -55.77 6.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.641 1.177 . . . . 0.0 110.015 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.36 -4.72 9.41 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.323 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -93.5 -58.8 2.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.728 1.264 . . . . 0.0 109.064 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -55.28 -30.41 60.08 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.064 0.946 . . . . 0.0 111.987 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 13' ' ' HIS . 7.5 p -38.04 -77.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 C-N-CA 125.477 1.511 . . . . 0.0 112.506 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.726 ' H ' HG13 ' A' ' 12' ' ' VAL . 38.0 m80 -67.1 -41.12 86.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -42.89 -44.41 4.53 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 12.9 pt20 -92.67 -39.79 11.09 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.09 66.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 120.003 1.274 . . . . 0.0 109.91 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -16.97 61.11 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.917 -0.489 . . . . 0.0 109.94 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.3 -62.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.304 1.041 . . . . 0.0 109.241 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.88 -47.07 78.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.298 1.439 . . . . 0.0 111.158 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.18 -48.33 73.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.008 0.822 . . . . 0.0 109.472 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.89 72.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.217 0.607 . . . . 0.0 110.922 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.02 -50.47 70.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.716 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -51.99 65.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 HG13 HG21 ' A' ' 31' ' ' ILE . 56.1 t -58.51 -56.08 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.492 0.717 . . . . 0.0 110.193 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.45 -55.04 30.54 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 m -82.75 17.4 1.86 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -144.02 39.71 1.35 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.345 1.058 . . . . 0.0 108.85 169.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -54.65 -44.17 73.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.779 0.831 . . . . 0.0 110.008 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.89 -26.91 27.74 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.566 1.079 . . . . 0.0 113.14 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.96 -53.6 4.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.158 0.979 . . . . 0.0 110.193 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.472 HG21 HG13 ' A' ' 24' ' ' VAL . 2.0 mp -67.79 -5.25 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.529 0.732 . . . . 0.0 112.385 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -32.5 -43.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 127.756 2.422 . . . . 0.0 112.052 169.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.12 -54.38 4.53 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.615 0.643 . . . . 0.0 112.777 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.73 -38.99 84.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.426 1.09 . . . . 0.0 110.442 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -56.52 -45.64 80.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.1 t -72.53 -43.01 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.41 97.27 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.62 -33.2 66.5 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.2 t -72.68 -10.77 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 122.876 0.471 . . . . 0.0 110.577 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.01 -43.88 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 O-C-N 121.521 -0.737 . . . . 0.0 111.169 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.414 HG22 ' H ' ' A' ' 42' ' ' ALA . 6.2 mt -108.19 173.63 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 41' ' ' ILE . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 116.502 -1.713 . . . . 0.0 111.101 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 119.892 -0.099 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.67 -63.24 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.36 0.664 . . . . 0.0 109.656 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -155.89 -179.93 8.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 t80 65.97 -12.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 115.034 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -130.77 -48.29 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.618 1.967 . . . . 0.0 108.9 166.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -55.69 -35.16 65.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.291 1.036 . . . . 0.0 112.789 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -98.95 -53.11 3.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.896 1.278 . . . . 0.0 110.774 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 p -54.63 -42.19 70.91 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.598 -0.715 . . . . 0.0 110.022 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -45.54 -36.24 5.96 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.141 0.882 . . . . 0.0 112.648 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -71.22 -70.79 0.29 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -49.9 -39.9 41.35 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.097 0.959 . . . . 0.0 113.364 -170.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -36.22 -64.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 C-N-CA 125.961 1.705 . . . . 0.0 109.837 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -70.14 -45.94 65.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -41.89 -39.94 1.97 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.35 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -101.33 -43.45 5.95 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -35.65 65.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.985 1.266 . . . . 0.0 108.633 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.14 -16.34 61.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.3 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.68 -53.47 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.609 1.163 . . . . 0.0 109.911 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -52.65 -49.46 65.15 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.724 1.61 . . . . 0.0 110.316 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.57 -47.16 87.4 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.586 0.63 . . . . 0.0 109.852 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.84 83.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.574 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -58.73 -49.73 76.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.96 0.504 . . . . 0.0 111.672 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -29.31 69.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.531 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.82 -56.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.41 0.624 . . . . 0.0 110.253 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.62 -49.78 67.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.65 1.119 . . . . 0.0 110.767 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -102.25 36.55 2.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.918 0.887 . . . . 0.0 111.027 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -153.46 37.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.811 0.815 . . . . 0.0 110.097 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -56.46 -43.9 80.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.685 -0.634 . . . . 0.0 109.931 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.33 -29.58 2.57 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.518 1.056 . . . . 0.0 113.316 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.56 7.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.944 0.898 . . . . 0.0 110.939 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.82 -27.15 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.568 0.699 . . . . 0.0 112.387 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.74 167.72 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.861 2.064 . . . . 0.0 112.114 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.27 -75.95 2.28 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.64 -27.28 68.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 117.682 0.741 . . . . 0.0 112.185 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -67.65 -34.37 76.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.95 -35.54 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.681 0.792 . . . . 0.0 110.138 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.29 -49.02 7.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.76 -27.42 71.08 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.604 -0.939 . . . . 0.0 111.822 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.78 -5.6 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 117.93 0.865 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.26 -51.57 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.42 -0.8 . . . . 0.0 109.497 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.0 tt -68.72 153.72 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.846 0.832 . . . . 0.0 111.216 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 128.065 2.546 . . . . 0.0 112.025 -177.424 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.95 -37.62 0.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.582 1.537 . . . . 0.0 111.719 169.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.75 -50.94 62.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.27 -55.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.095 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -52.66 -53.29 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.223 1.409 . . . . 0.0 111.586 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -62.96 -47.2 84.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.66 78.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.988 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -59.18 -53.44 58.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.78 0.832 . . . . 0.0 110.057 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.16 -48.24 71.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.342 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.47 -49.62 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.355 0.598 . . . . 0.0 111.072 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -53.84 41.21 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 123.329 0.651 . . . . 0.0 112.024 177.3 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -36.83 75.79 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.613 1.551 . . . . 0.0 109.522 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.04 -49.51 15.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -167.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -57.45 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.369 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -57.03 -57.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.327 0.651 . . . . 0.0 109.586 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.3 -48.34 80.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.58 -45.07 73.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.463 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.3 -49.14 76.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.008 0.822 . . . . 0.0 111.652 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -10.05 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.953 0.901 . . . . 0.0 112.65 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -97.11 -60.4 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.433 1.493 . . . . 0.0 109.475 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -49.43 63.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 125.517 1.532 . . . . 0.0 110.85 -170.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 122.861 0.464 . . . . 0.0 110.666 -179.316 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -35.68 81.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.71 -50.9 65.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.33 -59.22 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.535 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.84 -50.03 61.68 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 111.486 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -61.93 -51.11 69.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.83 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -60.89 -48.53 81.37 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.803 0.841 . . . . 0.0 112.022 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.82 -53.58 54.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 108.685 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.52 -51.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.686 0.794 . . . . 0.0 110.56 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.78 -50.74 56.9 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.4 m . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 123.773 0.829 . . . . 0.0 111.85 179.442 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -29.23 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.972 1.714 . . . . 0.0 109.449 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -10.45 59.4 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.297 0.373 . . . . 0.0 110.192 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.02 -58.86 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.002 1.321 . . . . 0.0 109.384 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -39.74 -55.1 1.99 Allowed 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 126.936 2.094 . . . . 0.0 111.61 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.31 -47.44 85.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.785 0.721 . . . . 0.0 110.371 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.81 90.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.088 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.78 -42.98 99.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.789 0.435 . . . . 0.0 111.955 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.7 -45.28 87.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.461 1.104 . . . . 0.0 108.974 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.04 -57.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.546 0.688 . . . . 0.0 110.358 171.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.39 -47.37 69.26 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.519 1.057 . . . . 0.0 110.638 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.451 -0.377 0 C-N-CA 123.628 0.771 . . . . 0.0 112.763 -176.811 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 CA--C 1.522 -0.131 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -59.83 -30.29 68.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.162 0.985 . . . . 0.0 109.124 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -69.5 -48.21 61.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.98 -51.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.74 -53.14 34.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 0.0 110.765 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.27 -47.96 83.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.227 -0.296 . . . . 0.0 110.355 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.83 -48.9 50.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.272 0.629 . . . . 0.0 109.613 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -51.46 68.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.371 0.668 . . . . 0.0 112.395 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -54.25 -50.16 67.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.763 0.825 . . . . 0.0 109.473 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.73 -55.08 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.871 0.868 . . . . 0.0 110.623 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.91 51.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 124.233 1.013 . . . . 0.0 112.227 179.596 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.49 -40.91 1.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.912 0.885 . . . . 0.0 111.578 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.79 -32.84 65.87 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -172.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.69 -58.54 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -50.22 -54.71 19.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.961 1.305 . . . . 0.0 111.093 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -61.45 -50.37 73.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.073 0.397 . . . . 0.0 110.197 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.81 67.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.145 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.25 -51.12 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.116 0.566 . . . . 0.0 111.704 174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.01 -19.27 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.014 0.926 . . . . 0.0 111.29 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -57.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 109.726 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.02 -50.94 58.76 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.934 1.255 . . . . 0.0 110.358 -169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 123.547 0.739 . . . . 0.0 111.351 179.379 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -35.29 60.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.396 1.453 . . . . 0.0 109.531 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.268 1.6 pp -77.3 -46.28 23.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.57 -48.33 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.846 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.36 -51.0 71.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.803 1.241 . . . . 0.0 110.004 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.91 -48.06 83.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.75 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.188 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.4 -44.74 86.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.99 -37.16 78.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.03 -53.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.483 0.659 . . . . 0.0 110.678 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.35 94.44 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -172.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.317 -172.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.253 24.6 pt20 . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.78 -36.37 16.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.612 1.551 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -25.02 55.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -171.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -89.96 -52.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.46 1.104 . . . . 0.0 109.524 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -48.32 -52.0 23.54 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.65 1.98 . . . . 0.0 109.952 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -58.12 -50.36 73.76 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.235 0.925 . . . . 0.0 110.744 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -49.52 65.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -56.96 -46.96 81.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.186 0.594 . . . . 0.0 112.465 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -8.55 48.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.604 1.162 . . . . 0.0 112.053 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.78 -57.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.847 1.259 . . . . 0.0 108.556 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.7 -56.56 15.31 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.295 1.426 . . . . 0.0 110.911 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.452 -0.354 0 C-N-CA 123.631 0.772 . . . . 0.0 112.446 -177.201 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 12.9 pt20 . . . . . 0 N--CA 1.445 -0.725 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.09 66.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 120.003 1.274 . . . . 0.0 109.91 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -16.97 61.11 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.917 -0.489 . . . . 0.0 109.94 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.3 -62.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.304 1.041 . . . . 0.0 109.241 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.88 -47.07 78.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.298 1.439 . . . . 0.0 111.158 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.18 -48.33 73.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.008 0.822 . . . . 0.0 109.472 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.89 72.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.217 0.607 . . . . 0.0 110.922 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.02 -50.47 70.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.716 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -51.99 65.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -58.51 -56.08 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.492 0.717 . . . . 0.0 110.193 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.45 -55.04 30.54 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -35.65 65.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.985 1.266 . . . . 0.0 108.633 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.14 -16.34 61.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.3 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.68 -53.47 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.609 1.163 . . . . 0.0 109.911 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -52.65 -49.46 65.15 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.724 1.61 . . . . 0.0 110.316 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.57 -47.16 87.4 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.586 0.63 . . . . 0.0 109.852 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.84 83.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.574 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -58.73 -49.73 76.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.96 0.504 . . . . 0.0 111.672 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -29.31 69.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.531 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.82 -56.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.41 0.624 . . . . 0.0 110.253 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.62 -49.78 67.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.65 1.119 . . . . 0.0 110.767 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 123.918 0.887 . . . . 0.0 111.027 -176.388 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.2 -72.13 0.18 Allowed 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.406 0.683 . . . . 0.0 109.262 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -140.05 5.11 2.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.506 0.722 . . . . 0.0 112.815 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.98 -33.71 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.402 0.681 . . . . 0.0 110.56 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -75.56 -57.16 4.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.919 0.888 . . . . 0.0 110.941 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -77.87 58.42 1.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.748 0.819 . . . . 0.0 111.657 -170.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.38 -60.46 1.52 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 109.853 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -53.4 -51.21 63.28 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.9 -0.5 . . . . 0.0 110.732 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.36 -14.73 57.74 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.836 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.33 -54.74 4.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.024 1.412 . . . . 0.0 108.566 171.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.91 -30.2 70.73 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.138 1.375 . . . . 0.0 112.94 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.73 HG13 ' H ' ' A' ' 13' ' ' HIS . 3.9 p -44.31 -80.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.147 0.979 . . . . 0.0 110.879 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.73 ' H ' HG13 ' A' ' 12' ' ' VAL . 48.9 m80 -58.92 -39.69 82.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.867 0.867 . . . . 0.0 110.812 -174.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -44.49 -37.74 3.68 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.414 0.446 . . . . 0.0 110.298 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -98.21 -52.7 3.59 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.95 -37.62 0.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.582 1.537 . . . . 0.0 111.719 169.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.4 mt -65.75 -50.94 62.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.27 -55.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.095 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -52.66 -53.29 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.223 1.409 . . . . 0.0 111.586 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -62.96 -47.2 84.23 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.66 78.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.988 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -59.18 -53.44 58.27 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.78 0.832 . . . . 0.0 110.057 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -54.16 -48.24 71.09 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.342 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.47 -49.62 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.355 0.598 . . . . 0.0 111.072 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -53.84 41.21 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 m -81.26 30.11 0.34 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.329 0.651 . . . . 0.0 112.024 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -156.6 32.36 0.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.176 0.99 . . . . 0.0 110.394 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -58.4 -39.39 79.57 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.74 0.816 . . . . 0.0 109.834 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.44 -31.75 5.05 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.028 0.823 . . . . 0.0 112.353 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.54 -54.23 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.521 0.661 . . . . 0.0 110.489 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.257 2.0 mp -64.56 -10.46 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -31.51 -41.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 127.9 2.48 . . . . 0.0 112.657 167.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.56 -53.57 12.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.571 0.623 . . . . 0.0 112.067 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.85 -41.0 83.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.402 1.081 . . . . 0.0 109.862 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -54.88 -51.15 66.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.01 -44.64 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.349 0.66 . . . . 0.0 109.598 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.38 -27.97 61.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.436 1.017 . . . . 0.0 111.63 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.5 -16.6 48.8 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.511 1.053 . . . . 0.0 112.52 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 t -79.65 -36.37 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.708 1.254 . . . . 0.0 110.228 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.12 -40.0 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 42' ' ' ALA . 1.6 mp -96.44 176.88 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 41' ' ' ILE . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.7 -1.619 . . . . 0.0 111.322 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.34 -63.58 0.38 Allowed 'General case' 0 C--N 1.338 0.093 0 C-N-CA 126.21 1.804 . . . . 0.0 111.718 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -105.59 157.09 17.64 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.8 t80 77.83 -50.41 0.51 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.998 1.719 . . . . 0.0 110.675 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.18 -32.96 72.62 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.106 0.962 . . . . 0.0 110.947 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -56.79 -25.61 55.89 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.37 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.37 31.43 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.149 1.779 . . . . 0.0 113.347 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m -52.79 -50.05 64.37 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.84 1.2 . . . . 0.0 111.067 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.38 -33.35 70.63 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 -62.01 1.7 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -48.05 -33.49 8.12 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 127.205 2.202 . . . . 0.0 112.467 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -46.18 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.329 1.052 . . . . 0.0 110.7 172.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -77.63 -41.56 38.0 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 122.905 0.482 . . . . 0.0 110.188 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -49.69 -46.38 49.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -88.34 -41.75 12.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -36.83 75.79 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.613 1.551 . . . . 0.0 109.522 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.04 -49.51 15.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -167.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -57.45 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.369 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -57.03 -57.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.327 0.651 . . . . 0.0 109.586 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.3 -48.34 80.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.58 -45.07 73.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.463 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -62.3 -49.14 76.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.008 0.822 . . . . 0.0 111.652 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -10.05 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.953 0.901 . . . . 0.0 112.65 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -97.11 -60.4 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.433 1.493 . . . . 0.0 109.475 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -49.43 63.38 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 125.517 1.532 . . . . 0.0 110.85 -170.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -96.22 35.44 1.45 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.861 0.464 . . . . 0.0 110.666 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -152.37 30.33 0.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.124 0.964 . . . . 0.0 110.137 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.07 -41.43 78.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.711 1.604 . . . . 0.0 110.275 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.95 22.6 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.677 1.132 . . . . 0.0 112.744 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.89 -50.91 5.32 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.738 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 mm -60.57 -13.04 5.68 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -32.4 -39.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 127.082 2.153 . . . . 0.0 111.551 165.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.85 -61.35 5.32 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.985 0.812 . . . . 0.0 112.782 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -67.18 -31.61 72.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.027 1.331 . . . . 0.0 111.563 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -62.19 -45.6 92.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.1 -40.77 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.559 0.744 . . . . 0.0 110.289 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.69 -42.07 27.29 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.84 -39.25 34.12 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -66.72 -13.49 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 117.424 0.612 . . . . 0.0 111.205 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.25 -40.44 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.771 0.828 . . . . 0.0 110.585 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 42' ' ' ALA . 1.5 mp -108.42 170.46 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 41' ' ' ILE . . . . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.288 -1.815 . . . . 0.0 110.741 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 t70 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 171.45 -62.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.822 0.849 . . . . 0.0 110.095 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -153.18 178.8 9.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.297 1.039 . . . . 0.0 108.47 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 t80 69.03 -24.75 0.14 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.178 1.791 . . . . 0.0 113.659 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -122.54 -52.07 1.93 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.219 2.207 . . . . 0.0 109.316 169.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -78.15 62.54 2.9 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.185 0.994 . . . . 0.0 108.454 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.52 -64.01 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.741 2.016 . . . . 0.0 105.694 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 m -48.39 -51.42 26.64 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.426 0.557 . . . . 0.0 112.166 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.03 -11.8 74.86 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.305 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -84.26 -49.55 8.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.515 1.158 . . . . 0.0 108.089 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -72.43 -13.98 61.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 116.278 -1.82 . . . . 0.0 114.169 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG13 ' H ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -49.65 -89.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 CA-C-N 120.209 1.368 . . . . 0.0 108.429 172.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.642 ' H ' HG13 ' A' ' 12' ' ' VAL . 68.6 m80 -49.81 -44.09 49.02 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.816 1.247 . . . . 0.0 111.254 -168.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -35.55 -50.36 0.59 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 112.248 170.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.11 -19.99 13.16 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.104 0.962 . . . . 0.0 113.512 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -35.68 81.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.71 -50.9 65.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.33 -59.22 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.535 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.84 -50.03 61.68 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 111.486 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -61.93 -51.11 69.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.83 70.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -60.89 -48.53 81.37 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.803 0.841 . . . . 0.0 112.022 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.82 -53.58 54.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 108.685 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.52 -51.42 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.686 0.794 . . . . 0.0 110.56 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.78 -50.74 56.9 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.4 m -86.9 29.98 0.78 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.773 0.829 . . . . 0.0 111.85 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -160.29 34.03 0.17 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.853 0.861 . . . . 0.0 111.238 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -56.49 -43.85 80.07 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.786 0.834 . . . . 0.0 109.855 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -42.9 -32.88 1.53 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.822 1.201 . . . . 0.0 112.912 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.18 -48.11 6.35 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 117.73 0.765 . . . . 0.0 111.279 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.45 -9.81 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.521 0.677 . . . . 0.0 112.565 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.09 159.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.526 1.93 . . . . 0.0 112.929 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.12 -84.03 1.01 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.06 -26.8 67.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 118.139 0.97 . . . . 0.0 112.193 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.79 -27.0 67.23 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 122.109 -0.369 . . . . 0.0 110.794 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.7 -49.69 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.77 -23.35 75.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.164 1.364 . . . . 0.0 112.429 -170.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.91 -11.64 54.45 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.229 -0.762 . . . . 0.0 111.533 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.89 40.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 118.188 0.994 . . . . 0.0 108.569 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.1 t -56.67 -50.61 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 123.884 0.874 . . . . 0.0 110.014 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.58 161.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 C-N-CA 126.435 1.894 . . . . 0.0 108.796 179.55 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.75 -68.21 0.09 Allowed 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.496 0.719 . . . . 0.0 109.418 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.4 -6.57 2.94 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.362 1.065 . . . . 0.0 112.959 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -46.11 -46.09 16.81 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 125.41 1.484 . . . . 0.0 110.239 173.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -68.67 -27.64 66.16 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.288 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -89.09 -135.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.2 t0 57.22 34.41 24.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.892 0.854 . . . . 0.0 109.812 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -69.65 -61.15 1.9 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 126.316 1.846 . . . . 0.0 109.126 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -48.83 -31.48 10.2 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 123.716 0.674 . . . . 0.0 112.649 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -71.93 -64.78 0.87 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.06 -0.671 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -44.82 -44.78 9.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.21 1.404 . . . . 0.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -37.18 -62.36 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 C-N-CA 125.428 1.491 . . . . 0.0 110.906 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -71.01 -45.41 64.02 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -45.46 -43.65 11.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 124.07 0.856 . . . . 0.0 109.904 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -90.98 -39.23 12.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -29.23 70.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.972 1.714 . . . . 0.0 109.449 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -10.45 59.4 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 123.297 0.373 . . . . 0.0 110.192 -177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.02 -58.86 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.002 1.321 . . . . 0.0 109.384 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -39.74 -55.1 1.99 Allowed 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 126.936 2.094 . . . . 0.0 111.61 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.31 -47.44 85.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.785 0.721 . . . . 0.0 110.371 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.81 90.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.088 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.78 -42.98 99.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.789 0.435 . . . . 0.0 111.955 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.7 -45.28 87.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.461 1.104 . . . . 0.0 108.974 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.04 -57.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.546 0.688 . . . . 0.0 110.358 171.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.39 -47.37 69.26 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.519 1.057 . . . . 0.0 110.638 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 m -85.84 16.74 3.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.628 0.771 . . . . 0.0 112.763 -176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -144.51 48.47 1.35 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.556 1.142 . . . . 0.0 109.166 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -52.06 -44.9 64.51 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -46.1 -31.69 4.53 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.723 1.154 . . . . 0.0 112.834 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.53 -51.76 4.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.726 0.763 . . . . 0.0 111.316 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.73 -2.35 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.866 0.841 . . . . 0.0 112.764 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -36.44 159.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 129.353 3.061 . . . . 0.0 114.85 172.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.13 -80.01 1.86 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.33 -32.65 72.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.936 0.868 . . . . 0.0 111.962 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -26.76 66.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 122.945 0.498 . . . . 0.0 110.788 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -87.53 -34.78 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.203 0.601 . . . . 0.0 109.97 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.9 -49.58 6.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.94 -26.44 62.36 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.04 0.828 . . . . 0.0 112.253 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.89 -12.36 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 117.521 0.661 . . . . 0.0 111.252 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.73 -35.13 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 123.36 0.664 . . . . 0.0 111.293 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 mm -102.46 166.35 2.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 C-N-CA 124.67 1.188 . . . . 0.0 111.292 -177.581 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 72.1 -32.83 0.25 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.056 1.742 . . . . 0.0 114.408 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.13 3.64 5.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.863 1.665 . . . . 0.0 111.285 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.1 -52.72 57.85 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -62.44 -51.09 68.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.447 -169.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -61.82 -25.8 67.73 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -87.8 21.9 2.48 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 111.857 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.8 p -44.33 -57.01 3.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.069 1.304 . . . . 0.0 111.631 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.99 -8.06 26.95 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.485 1.041 . . . . 0.0 114.811 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -99.23 -54.94 2.83 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.257 1.423 . . . . 0.0 108.429 174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.71 -43.3 26.67 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.724 2.009 . . . . 0.0 111.382 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 13' ' ' HIS . 8.7 p -39.51 -72.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.735 0 C-N-CA 124.85 1.26 . . . . 0.0 110.999 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.648 ' H ' HG13 ' A' ' 12' ' ' VAL . 36.3 m80 -58.25 -47.55 83.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.222 1.009 . . . . 0.0 110.327 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -47.35 -44.99 24.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.927 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -93.77 -35.37 12.8 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -59.83 -30.29 68.84 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.162 0.985 . . . . 0.0 109.124 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -69.5 -48.21 61.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.98 -51.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.74 -53.14 34.01 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 0.0 110.765 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -61.27 -47.96 83.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.227 -0.296 . . . . 0.0 110.355 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.83 -48.9 50.67 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.272 0.629 . . . . 0.0 109.613 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -51.46 68.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.371 0.668 . . . . 0.0 112.395 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -54.25 -50.16 67.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.763 0.825 . . . . 0.0 109.473 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.73 -55.08 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.871 0.868 . . . . 0.0 110.623 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.46 -50.91 51.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 m -86.9 28.59 0.88 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.233 1.013 . . . . 0.0 112.227 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -159.94 36.14 0.18 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.65 0.738 . . . . 0.0 112.133 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -55.41 -45.69 76.66 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.077 0.951 . . . . 0.0 109.976 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -43.32 -32.76 1.85 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.959 1.266 . . . . 0.0 112.782 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.2 -48.95 6.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.668 0.734 . . . . 0.0 111.119 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.27 3.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.341 1.067 . . . . 0.0 112.272 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -51.96 162.81 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.574 1.95 . . . . 0.0 112.712 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.15 3.41 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -45.7 81.58 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 118.25 1.025 . . . . 0.0 109.716 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.7 tpt -53.29 -50.48 64.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.146 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -63.95 -43.56 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.511 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.44 73.3 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.247 1.403 . . . . 0.0 111.294 -172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -51.73 5.94 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -75.9 -19.45 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.627 0.713 . . . . 0.0 112.603 -166.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p -51.74 -39.27 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.747 0.819 . . . . 0.0 112.448 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -98.95 157.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.218 0 CA-C-O 116.742 -1.599 . . . . 0.0 109.105 178.476 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.32 68.03 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 109.054 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 66.31 -2.17 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.939 1.696 . . . . 0.0 114.738 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -57.53 -36.14 71.21 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.571 0.748 . . . . 0.0 111.084 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -64.44 -53.98 39.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.233 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -76.67 43.27 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.656 0.782 . . . . 0.0 112.022 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.48 -73.13 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.271 167.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -55.33 -45.63 76.39 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 118.798 0.726 . . . . 0.0 110.954 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.89 -18.61 54.28 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.956 0.798 . . . . 0.0 113.604 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -88.53 -57.91 2.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.636 1.218 . . . . 0.0 109.205 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -62.58 -22.76 66.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.109 2.163 . . . . 0.0 112.679 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.763 HG13 ' H ' ' A' ' 13' ' ' HIS . 5.3 p -51.09 -85.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 C-N-CA 124.653 1.181 . . . . 0.0 109.83 -175.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.763 ' H ' HG13 ' A' ' 12' ' ' VAL . 48.7 m80 -51.59 -44.11 62.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.032 0.933 . . . . 0.0 111.313 -175.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -38.57 -41.28 0.66 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.803 0.841 . . . . 0.0 111.487 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.89 -45.98 4.62 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.49 -40.91 1.32 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.912 0.885 . . . . 0.0 111.578 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.79 -32.84 65.87 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -172.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.69 -58.54 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -50.22 -54.71 19.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.961 1.305 . . . . 0.0 111.093 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -61.45 -50.37 73.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.073 0.397 . . . . 0.0 110.197 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.81 67.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.145 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.25 -51.12 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.116 0.566 . . . . 0.0 111.704 174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -66.01 -19.27 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.014 0.926 . . . . 0.0 111.29 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.0 t -86.44 -57.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 109.726 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.02 -50.94 58.76 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 124.934 1.255 . . . . 0.0 110.358 -169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 m -90.15 32.3 0.94 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.547 0.739 . . . . 0.0 111.351 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -153.45 31.45 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.084 0.945 . . . . 0.0 110.58 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -60.58 -41.08 93.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.955 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.47 -31.15 3.38 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.817 1.198 . . . . 0.0 112.91 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.62 -46.64 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.663 0.731 . . . . 0.0 110.734 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.91 -23.7 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.506 0.67 . . . . 0.0 112.514 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -54.63 168.38 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.802 2.041 . . . . 0.0 112.515 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.96 -77.0 2.17 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.09 -27.96 69.29 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 117.719 0.76 . . . . 0.0 111.896 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -42.95 99.86 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.96 -33.57 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.77 -42.01 7.43 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.392 0.996 . . . . 0.0 110.922 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.73 -42.74 93.01 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.31 -19.38 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.884 0.473 . . . . 0.0 111.293 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -47.39 -41.69 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.246 1.018 . . . . 0.0 111.27 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mp -112.92 162.25 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.788 1.635 . . . . 0.0 109.034 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.29 53.05 2.17 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.004 -0.435 . . . . 0.0 110.675 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 62.88 9.69 3.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.606 1.562 . . . . 0.0 112.534 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -64.09 -45.31 89.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -72.82 -49.1 32.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.299 -173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -69.49 -13.11 62.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -59.88 4.31 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.364 0.529 . . . . 0.0 111.143 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 m -54.25 -49.19 70.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.639 0.2 . . . . 0.0 111.505 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -39.79 48.19 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 111.609 -0.597 . . . . 0.0 111.609 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -82.31 5.18 20.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -123.99 -49.23 1.85 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.667 1.187 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 t -40.79 -61.14 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 C-N-CA 125.21 1.404 . . . . 0.0 111.544 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -71.09 -43.68 67.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -53.79 -38.13 64.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.217 0.607 . . . . 0.0 109.463 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -86.04 -44.22 12.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -35.29 60.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.396 1.453 . . . . 0.0 109.531 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.268 1.6 pp -77.3 -46.28 23.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.57 -48.33 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.846 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.36 -51.0 71.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.803 1.241 . . . . 0.0 110.004 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.91 -48.06 83.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.75 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.188 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -65.4 -44.74 86.5 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.99 -37.16 78.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.03 -53.86 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.483 0.659 . . . . 0.0 110.678 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.41 -40.35 94.44 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -172.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.65 31.1 6.41 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.317 -172.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -148.27 39.69 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.431 1.11 . . . . 0.0 109.754 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -58.1 -44.58 87.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.514 -174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.16 -33.09 3.76 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.508 1.051 . . . . 0.0 112.843 173.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.06 -57.6 3.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.284 0.633 . . . . 0.0 109.375 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -43.35 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 121.18 0.514 . . . . 0.0 111.201 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.8 mt -43.04 -53.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.674 1.99 . . . . 0.0 110.772 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.3 -46.1 72.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 mt -74.11 -23.49 59.32 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.92 1.288 . . . . 0.0 112.302 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -51.72 65.86 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 t -65.96 -47.1 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.039 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.84 -32.99 63.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.027 0.822 . . . . 0.0 111.499 -170.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.38 -36.87 15.97 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.0 34.05 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 122.098 0.952 . . . . 0.0 109.351 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -56.1 -42.84 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.465 1.106 . . . . 0.0 111.335 173.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.04 166.19 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.125 1.37 . . . . 0.0 111.278 -177.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.36 -82.64 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.232 0.613 . . . . 0.0 109.356 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -154.79 39.05 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.467 1.907 . . . . 0.0 107.209 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -98.39 -23.22 15.69 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.284 0.633 . . . . 0.0 110.593 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -105.57 -49.08 3.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.907 0.883 . . . . 0.0 112.031 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -75.65 1.98 13.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.652 -0.655 . . . . 0.0 112.644 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -73.72 25.42 0.07 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.692 -1.255 . . . . 0.0 113.699 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 m -57.65 -48.51 79.28 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.485 1.039 . . . . 0.0 110.473 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -16.58 56.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.362 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -90.24 -57.71 2.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.246 1.019 . . . . 0.0 108.817 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -62.03 -29.36 70.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.896 1.278 . . . . 0.0 113.225 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.559 HG13 ' H ' ' A' ' 13' ' ' HIS . 6.1 p -41.73 -63.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 C-N-CA 124.566 1.146 . . . . 0.0 111.427 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.559 ' H ' HG13 ' A' ' 12' ' ' VAL . 47.8 m80 -65.37 -46.71 79.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.522 1.129 . . . . 0.0 110.173 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.89 -45.1 10.13 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 123.436 0.46 . . . . 0.0 109.981 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.253 24.6 pt20 -86.86 -50.67 6.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -48.78 -36.37 16.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.612 1.551 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -25.02 55.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -171.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -89.96 -52.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.46 1.104 . . . . 0.0 109.524 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -48.32 -52.0 23.54 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.65 1.98 . . . . 0.0 109.952 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -58.12 -50.36 73.76 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 119.235 0.925 . . . . 0.0 110.744 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.85 -49.52 65.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -56.96 -46.96 81.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.186 0.594 . . . . 0.0 112.465 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -8.55 48.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.604 1.162 . . . . 0.0 112.053 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.78 -57.91 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.847 1.259 . . . . 0.0 108.556 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.7 -56.56 15.31 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.295 1.426 . . . . 0.0 110.911 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 m -84.88 21.87 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.631 0.772 . . . . 0.0 112.446 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -140.75 32.58 1.81 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.036 1.335 . . . . 0.0 109.049 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -42.55 91.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.83 0.852 . . . . 0.0 109.703 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.96 -27.76 22.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.597 1.094 . . . . 0.0 112.963 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.48 -51.64 5.03 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.956 0.878 . . . . 0.0 110.165 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mp -65.52 -10.25 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.488 0.715 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -33.04 -47.44 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 127.993 2.517 . . . . 0.0 113.667 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.53 -52.56 40.71 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.48 -27.22 64.05 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.122 1.369 . . . . 0.0 112.36 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttp -62.45 -53.68 51.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 171.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.68 -35.45 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.908 0.883 . . . . 0.0 110.711 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.21 -49.8 6.65 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.38 -37.68 95.02 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.66 -14.85 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 117.289 0.544 . . . . 0.0 111.547 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.64 -37.55 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 123.034 0.534 . . . . 0.0 110.925 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -107.82 167.01 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.65 1.18 . . . . 0.0 111.255 -177.234 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.75 103.03 0.07 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.602 1.561 . . . . 0.0 111.851 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 66.66 3.64 3.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.866 1.666 . . . . 0.0 113.929 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.3 -39.64 92.77 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -79.83 -33.4 40.3 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.487 1.515 . . . . 0.0 111.266 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -95.06 -128.15 0.13 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 t70 57.98 23.51 10.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 110.982 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -72.74 -55.77 6.26 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.641 1.177 . . . . 0.0 110.015 -171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.36 -4.72 9.41 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.164 -0.798 . . . . 0.0 113.323 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -93.5 -58.8 2.17 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.728 1.264 . . . . 0.0 109.064 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -55.28 -30.41 60.08 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.064 0.946 . . . . 0.0 111.987 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 13' ' ' HIS . 7.5 p -38.04 -77.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.807 0 C-N-CA 125.477 1.511 . . . . 0.0 112.506 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.726 ' H ' HG13 ' A' ' 12' ' ' VAL . 38.0 m80 -67.1 -41.12 86.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -172.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -42.89 -44.41 4.53 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 118.86 -0.59 . . . . 0.0 111.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 12.9 pt20 -92.67 -39.79 11.09 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.09 66.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 120.003 1.274 . . . . 0.0 109.91 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.86 -16.97 61.11 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.917 -0.489 . . . . 0.0 109.94 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.3 -62.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.304 1.041 . . . . 0.0 109.241 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -55.88 -47.07 78.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.298 1.439 . . . . 0.0 111.158 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -65.18 -48.33 73.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.008 0.822 . . . . 0.0 109.472 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.89 72.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.217 0.607 . . . . 0.0 110.922 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.02 -50.47 70.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.716 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -51.99 65.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 HG13 HG21 ' A' ' 31' ' ' ILE . 56.1 t -58.51 -56.08 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.492 0.717 . . . . 0.0 110.193 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.45 -55.04 30.54 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 m -82.75 17.4 1.86 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -144.02 39.71 1.35 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.345 1.058 . . . . 0.0 108.85 169.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -54.65 -44.17 73.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.779 0.831 . . . . 0.0 110.008 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.89 -26.91 27.74 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.566 1.079 . . . . 0.0 113.14 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.96 -53.6 4.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.158 0.979 . . . . 0.0 110.193 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.472 HG21 HG13 ' A' ' 24' ' ' VAL . 2.0 mp -67.79 -5.25 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.529 0.732 . . . . 0.0 112.385 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -32.5 -43.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 127.756 2.422 . . . . 0.0 112.052 169.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.12 -54.38 4.53 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.615 0.643 . . . . 0.0 112.777 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -67.73 -38.99 84.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.426 1.09 . . . . 0.0 110.442 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.0 tpt -56.52 -45.64 80.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.1 t -72.53 -43.01 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.41 97.27 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.62 -33.2 66.5 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.2 t -72.68 -10.77 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 122.876 0.471 . . . . 0.0 110.577 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.01 -43.88 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 O-C-N 121.521 -0.737 . . . . 0.0 111.169 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.414 HG22 ' H ' ' A' ' 42' ' ' ALA . 6.2 mt -108.19 173.63 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 41' ' ' ILE . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 116.502 -1.713 . . . . 0.0 111.101 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 119.892 -0.099 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.67 -63.24 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.36 0.664 . . . . 0.0 109.656 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -155.89 -179.93 8.6 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 t80 65.97 -12.37 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.465 1.506 . . . . 0.0 115.034 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -130.77 -48.29 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.618 1.967 . . . . 0.0 108.9 166.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -55.69 -35.16 65.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.291 1.036 . . . . 0.0 112.789 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -98.95 -53.11 3.36 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.896 1.278 . . . . 0.0 110.774 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 p -54.63 -42.19 70.91 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.598 -0.715 . . . . 0.0 110.022 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -45.54 -36.24 5.96 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.141 0.882 . . . . 0.0 112.648 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -71.22 -70.79 0.29 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -49.9 -39.9 41.35 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.097 0.959 . . . . 0.0 113.364 -170.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -36.22 -64.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 C-N-CA 125.961 1.705 . . . . 0.0 109.837 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -70.14 -45.94 65.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -41.89 -39.94 1.97 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.35 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -101.33 -43.45 5.95 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -35.65 65.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 119.985 1.266 . . . . 0.0 108.633 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.14 -16.34 61.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.3 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.68 -53.47 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.609 1.163 . . . . 0.0 109.911 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -52.65 -49.46 65.15 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.724 1.61 . . . . 0.0 110.316 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.57 -47.16 87.4 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.586 0.63 . . . . 0.0 109.852 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.84 83.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.574 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -58.73 -49.73 76.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.96 0.504 . . . . 0.0 111.672 172.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.53 -29.31 69.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.531 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.82 -56.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.41 0.624 . . . . 0.0 110.253 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.62 -49.78 67.59 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.65 1.119 . . . . 0.0 110.767 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -102.25 36.55 2.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.918 0.887 . . . . 0.0 111.027 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -153.46 37.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.811 0.815 . . . . 0.0 110.097 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -56.46 -43.9 80.01 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.685 -0.634 . . . . 0.0 109.931 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -45.33 -29.58 2.57 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.518 1.056 . . . . 0.0 113.316 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.4 -47.56 7.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.944 0.898 . . . . 0.0 110.939 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 mp -63.82 -27.15 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.568 0.699 . . . . 0.0 112.387 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.74 167.72 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.861 2.064 . . . . 0.0 112.114 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.27 -75.95 2.28 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -61.64 -27.28 68.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 117.682 0.741 . . . . 0.0 112.185 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -67.65 -34.37 76.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 t -84.95 -35.54 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 123.681 0.792 . . . . 0.0 110.138 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.29 -49.02 7.06 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.76 -27.42 71.08 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.604 -0.939 . . . . 0.0 111.822 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.78 -5.6 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 117.93 0.865 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.26 -51.57 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.42 -0.8 . . . . 0.0 109.497 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.0 tt -68.72 153.72 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.846 0.832 . . . . 0.0 111.216 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 128.065 2.546 . . . . 0.0 112.025 -177.424 . . . . . . . . 0 0 . 1 stop_ save_